NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) recently announced significant developments regarding its private placement agreement. On January 28, 2025, NRx Pharmaceuticals, Inc. entered into an Amended ...

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services ...

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...

Shares of NRx Pharmaceuticals Inc. surged nearly 25% on Tuesday, its best session in almost three weeks, drawing heavy ...

A Delaware-based biotech company turned heads on Tuesday after it was announced that it has invested $27 million in its ...

NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.

迈阿密 - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP )，一家目前市值为3437万美元的临床阶段生物制药公司，宣布达成一项融资协议，以支持其子公司HOPE Therapeutics, Inc.。该公司股票目前交易价格为2.85美元，显示出显著的波动性，尽管年初至今的回报率强劲达29.55%，但目前仍远低于其52周高点7.33美元。根据 InvestingPro ...

NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with ...

NRx Pharmaceuticals, Inc. appointed Mike Taylor as a Class I member of its Board of Directors. Taylor, aged 50, brings with him 25 years of experience in the global credit business, specializing in ...

Drilling is now underway at Noronex (ASX:NRX)’s Damara Copper Project in Namibia to test some high-potential ... Read our ...

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) ("NRx", the "Company"), a clinical-stage biopharmaceutical company, today announced ...